What is the share price of Healthcare Global Enterprises Ltd (HCG) today?
The share price of HCG as on 5th December 2025 is ₹714.35. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Healthcare Global Enterprises Ltd (HCG) share?
The past returns of Healthcare Global Enterprises Ltd (HCG) share are- Past 1 week: -2.08%
- Past 1 month: -4.36%
- Past 3 months: 3.04%
- Past 6 months: 29.59%
- Past 1 year: 42.70%
- Past 3 years: 135.01%
- Past 5 years: 388.28%
What are the peers or stocks similar to Healthcare Global Enterprises Ltd (HCG)?
The peers or stocks similar to Healthcare Global Enterprises Ltd (HCG) include:What is the market cap of Healthcare Global Enterprises Ltd (HCG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Healthcare Global Enterprises Ltd (HCG) is ₹10103.36 Cr as of 5th December 2025.What is the 52 week high and low of Healthcare Global Enterprises Ltd (HCG) share?
The 52-week high of Healthcare Global Enterprises Ltd (HCG) is ₹804.65 and the 52-week low is ₹456.95.What is the PE and PB ratio of Healthcare Global Enterprises Ltd (HCG) stock?
The P/E (price-to-earnings) ratio of Healthcare Global Enterprises Ltd (HCG) is 227.45. The P/B (price-to-book) ratio is 10.20.Which sector does Healthcare Global Enterprises Ltd (HCG) belong to?
Healthcare Global Enterprises Ltd (HCG) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Healthcare Global Enterprises Ltd (HCG) shares?
You can directly buy Healthcare Global Enterprises Ltd (HCG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Healthcare Global Enterprises Ltd
HCG Share Price
714.350.31% (-2.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
HCG Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
HCG Performance & Key Metrics
HCG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 285.73 | 10.20 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
83%
Analysts have suggested that investors can buy this stock
from 6 analysts
Price Upside
Earnings Growth
Rev. Growth
HCG Company Profile
Healthcare Global Enterprises Limited is a specialty healthcare provider. The Company is focused on cancer and fertility.
MAXHEALTH
PE Ratio
98.00
98.00
1Y Return
1.85%
1.85%
Buy Reco %
77.27
77.27
APOLLOHOSP
PE Ratio
71.61
71.61
1Y Return
0.43%
0.43%
Buy Reco %
86.21
86.21
FORTIS
PE Ratio
86.64
86.64
1Y Return
24.99%
24.99%
Buy Reco %
75.00
75.00
PE Ratio
49.80
49.80
1Y Return
47.18%
47.18%
Buy Reco %
77.78
77.78
ASTERDM
PE Ratio
6.28
6.28
1Y Return
34.87%
34.87%
Buy Reco %
100.00
100.00
HCG Sentiment Analysis
HCG Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
HCG Stock Summary · May 2025
The company demonstrated robust financial performance, reporting significant revenue growth of 20% in Q4 and 17% for the full year, driven by strong patient demand and operational efficiency, particularly in emerging centers. While challenges such as increased depreciation and interest costs from recent investments impacted profit after tax, management remains optimistic about future margins as new facilities stabilize. Strategic investments in advanced technologies and digital initiatives have enhanced patient access and outcomes, positioning the company as a leader in oncology care. Additionally, proactive measures to address competitive pressures and optimize working capital reflect a commitment to long-term growth and stakeholder engagement, despite navigating a complex market landscape.
HCG Stock Growth Drivers
HCG Stock Growth Drivers
9Strong Financial Performance
The company reported significant revenue growth, with a 20% increase in Q4 and a 17%
Infrastructure and Technological Advancements
The company has made significant investments in advanced cancer treatment technologies, including the acquisition of
HCG Stock Challenges
HCG Stock Challenges
5Revenue Loss Due to Government Scheme Withdrawal
The withdrawal of a government healthcare scheme in Odisha has resulted in a significant revenue
Integration Challenges of Newly Acquired Facility
The integration of the newly acquired Vizag facility has led to adjustments in operating costs,
HCG Forecast
HCG Forecasts
Price
Revenue
Earnings
HCG Share Price Forecast
HCG Share Price Forecast
2025
Current
₹716.55
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹716.55
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HCG Company Revenue Forecast
HCG Company Revenue Forecast
2025
Current
₹2.26
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹2.26
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
HCG Stock EPS (Earnings Per Share) Forecast
HCG Stock EPS (Earnings Per Share) Forecast
2025
Current
₹3.19
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹3.19
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HCG
HCG
Income
Balance Sheet
Cash Flow
Annual Normal View
HCG Income Statement
HCG Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 709.78 | 861.91 | 986.09 | 1,102.61 | 1,036.17 | 1,560.36 | 1,707.63 | 1,933.35 | 2,258.44 | 2,429.95 | ||||||||||
Raw Materials | 175.92 | 196.64 | 221.49 | 236.35 | 238.17 | 360.98 | 432.38 | 479.37 | 590.22 | 1,978.63 | ||||||||||
| Power & Fuel Cost | 16.42 | 22.89 | 28.82 | 33.26 | 31.75 | 34.54 | 36.89 | 39.35 | 43.97 | |||||||||||
| Employee Cost | 121.93 | 157.71 | 184.52 | 208.03 | 195.94 | 233.65 | 275.12 | 308.24 | 353.48 | |||||||||||
| Selling & Administrative Expenses | 83.00 | 285.43 | 362.38 | 367.58 | 333.50 | 430.81 | 526.94 | 195.85 | 205.40 | |||||||||||
| Operating & Other expenses | 197.85 | 58.25 | 67.25 | 90.56 | 187.09 | 156.57 | 124.46 | 559.73 | 642.50 | |||||||||||
EBITDA | 114.66 | 140.99 | 121.63 | 166.83 | 49.72 | 343.81 | 311.84 | 350.81 | 422.87 | 451.32 | ||||||||||
| Depreciation/Amortization | 56.83 | 71.46 | 85.09 | 148.45 | 159.22 | 158.28 | 163.47 | 174.36 | 211.34 | 235.30 | ||||||||||
| PBIT | 57.83 | 69.53 | 36.54 | 18.38 | -109.50 | 185.53 | 148.37 | 176.45 | 211.53 | 216.02 | ||||||||||
| Interest & Other Items | 23.00 | 42.35 | 69.91 | 137.65 | 119.17 | 97.77 | 103.50 | 108.74 | 154.56 | 173.96 | ||||||||||
| PBT | 34.83 | 27.18 | -33.37 | -119.27 | -228.67 | 87.76 | 44.87 | 67.71 | 56.97 | 42.06 | ||||||||||
| Taxes & Other Items | 12.67 | 6.65 | -8.58 | -12.57 | -35.20 | 34.04 | 15.53 | 19.58 | 12.55 | 6.70 | ||||||||||
| Net Income | 22.16 | 20.53 | -24.79 | -106.70 | -193.47 | 53.72 | 29.34 | 48.13 | 44.42 | 35.36 | ||||||||||
| EPS | 2.60 | 2.38 | -2.84 | -12.08 | -18.08 | 4.06 | 2.11 | 3.46 | 3.19 | 2.54 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HCG Company Updates
FY 2026FY 2026
Investor Presentation
Dec 4PDF
Nov 12PDF
Aug 1PDF
HCG Stock Peers
HCG Past Performance & Peer Comparison
HCG Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Healthcare Global Enterprises Ltd | 227.45 | 10.20 | — |
| Max Healthcare Institute Ltd | 98.00 | 11.24 | 0.14% |
| Apollo Hospitals Enterprise Ltd | 71.61 | 9.33 | 0.18% |
| Fortis Healthcare Ltd | 86.64 | 7.32 | 0.11% |
HCG Stock Price Comparison
Compare HCG with any stock or ETFCompare HCG with any stock or ETF
HCG
HCG Holdings
HCG Shareholdings
HCG Promoter Holdings Trend
HCG Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 7.44%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
HCG Institutional Holdings Trend
HCG Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 1.43%
HCG Shareholding Pattern
HCG Shareholding Pattern
HCG Shareholding History
HCG Shareholding History
Foreign Institutions
Mutual Funds Invested in HCG
Mutual Funds Invested in HCG
No mutual funds holding trends are available
Top 5 Mutual Funds holding Healthcare Global Enterprises Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.2538% | Percentage of the fund’s portfolio invested in the stock 0.48% | Change in the portfolio weight of the stock over the last 3 months 0.48% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 198/252 (+48) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.5883% | Percentage of the fund’s portfolio invested in the stock 1.69% | Change in the portfolio weight of the stock over the last 3 months 0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 41/69 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4034% | Percentage of the fund’s portfolio invested in the stock 5.28% | Change in the portfolio weight of the stock over the last 3 months 1.51% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/26 (+4) |
Compare 3-month MF holding change on Screener
smallcases containing HCG stock
smallcases containing HCG stock
Looks like this stock is not in any smallcase yet.
HCG Events
HCG Events
HCG Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HCG has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
HCG Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HCG has not given any dividends in last 5 years
HCG Dividends
HCG Dividends
Hmm, looks like data is unavailable here. Please come back after some timeHCG Stock News & Opinions
HCG Stock News & Opinions
Articles & Videos
Corporate
HealthCare Global Enterprises appoints Manish Mattoo as Interim CFO
HealthCare Global Enterprises has appointed Manish Mattoo, Executive Director and Chief Executive Officer, as the interim Chief Financial Officer and Key Managerial Personnel of the Company. The appointment shall be effective from 01 December 2025, and shall remain in force until a new Chief Financial Officer is appointed by the Board of Directors and assumes office as the Chief Financial Officer.Powered by Capital Market - Live
3 days agoCapital Market - Live
Earnings
Healthcare Global Enterprises consolidated net profit declines 9.56% in the September 2025 quarter
Net profit of Healthcare Global Enterprises declined 9.56% to Rs 16.27 crore in the quarter ended September 2025 as against Rs 17.99 crore during the previous quarter ended September 2024. Sales rose 16.78% to Rs 645.16 crore in the quarter ended September 2025 as against Rs 552.47 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales645.16552.47 17 OPM %19.1118.51 - PBDT82.6277.39 7 PBT19.8227.65 -28 NP16.2717.99 -10 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Healthcare Global Enterprises standalone net profit declines 39.94% in the September 2025 quarter
Net profit of Healthcare Global Enterprises declined 39.94% to Rs 10.78 crore in the quarter ended September 2025 as against Rs 17.95 crore during the previous quarter ended September 2024. Sales rose 4.86% to Rs 344.41 crore in the quarter ended September 2025 as against Rs 328.45 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales344.41328.45 5 OPM %18.0918.75 - PBDT44.7650.79 -12 PBT14.6022.91 -36 NP10.7817.95 -40 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Healthcare Global Enterprises to conduct board meeting
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Healthcare Global Enterprises to convene AGM
Healthcare Global Enterprises announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Healthcare Global Enterprises consolidated net profit declines 60.68% in the June 2025 quarter
Net profit of Healthcare Global Enterprises declined 60.68% to Rs 4.75 crore in the quarter ended June 2025 as against Rs 12.08 crore during the previous quarter ended June 2024. Sales rose 16.60% to Rs 611.80 crore in the quarter ended June 2025 as against Rs 524.69 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales611.80524.69 17 OPM %17.6217.32 - PBDT69.8366.00 6 PBT11.9218.99 -37 NP4.7512.08 -61 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Healthcare Global Enterprises to declare Quarterly Results
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Healthcare Global Enterprises consolidated net profit declines 65.38% in the March 2025 quarter
Net profit of Healthcare Global Enterprises declined 65.38% to Rs 7.36 crore in the quarter ended March 2025 as against Rs 21.26 crore during the previous quarter ended March 2024. Sales rose 18.28% to Rs 583.43 crore in the quarter ended March 2025 as against Rs 493.25 crore during the previous quarter ended March 2024. For the full year,net profit declined 7.75% to Rs 44.41 crore in the year ended March 2025 as against Rs 48.14 crore during the previous year ended March 2024. Sales rose 16.26% to Rs 2218.14 crore in the year ended March 2025 as against Rs 1907.87 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales583.43493.25 18 2218.141907.87 16 OPM %18.1118.66 -17.4617.28 - PBDT71.6970.30 2 268.30238.18 13 PBT13.6224.32 -44 56.9663.82 -11 NP7.3621.26 -65 44.4148.14 -8 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Healthcare Global Enterprises schedules board meeting
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 24 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Spotlight
HCG shares up as KKR set to steer the ship
The agreement, which involves a transaction with CVC, a global private markets manager, will see KKR acquire up to 54% of HCG's equity from CVC Asia V at a price of Rs 445 per share. In accordance with the Securities and Exchange Board of India (SEBI) Takeover Regulations, KKR will also conduct an open offer to purchase additional equity shares from public shareholders. Upon completion of the transaction, KKR's total equity stake in HCG is expected to range between 54% and 77%. Dr. BS Ajaikumar, the founder of HCG, will transition to the role of non-executive chairman, where he will focus on driving clinical, academic, and research and development excellence within the organization. The transaction is expected to close by the third quarter of 2025, subject to customary closing conditions and regulatory approvals. Separately, KKR has initiated an open offer to acquire up to 26% of HCG's expanded voting share capital, offering to purchase 3,70,90,327 equity shares at Rs 504.41 per share, for a total consideration of Rs 1870,87,31,842.07. Founded in 1989, HCG is one of India's largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities with best-in-class infrastructure including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LINACs). Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 15.42%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 2.65% to 2.83%